# The Drug Pipeline Aiming to Stop Age-Related Muscle Loss

*Strengthening muscle for healthy ageing: innovative treatments for sarcopenia.*

- **Evidence Level**: Moderate
- **Publication Types**: Journal Article, Review
- **Journal**: Nature reviews. Drug discovery
- **Sample Size**: N/A
- **Authors**: Ancel S, Le Moal E, Wang YX, Blau HM
- **Published**: 2026-09-07
- **Topics**: Sarcopenia, Muscle, Longevity Drugs
- **DOI**: https://doi.org/10.1038/s41573-026-01514-3
- **Original Source**: https://pubmed.ncbi.nlm.nih.gov/42706321/

## Summary

Losing muscle with age, called sarcopenia, raises the risk of falls, fractures, and early death. Right now there is no approved drug for it. This review walks through what's in development, including NAD+ boosters, urolithin A, myostatin blockers, and mTOR inhibitors like rapamycin. Researchers are also testing drugs alongside GLP-1 weight loss medications to stop people from losing muscle while they slim down.

## Practical Takeaway

This review suggests muscle-preserving drugs are still years away, so training and protein remain the main tools.

---

_Canonical: https://longevity-germany.com/en/research/the-drug-pipeline-aiming-to-stop-age-related-muscle-loss · Part of Longevity Cities · Updated 2026-09-07_